{
    "clinical_study": {
        "@rank": "31726", 
        "arm_group": {
            "arm_group_label": "NuNec Cervical Disc", 
            "arm_group_type": "Experimental", 
            "description": "Each patient will be implanted with the NuNec Cervical Disc in a single level from C3 to C7.  Postoperatively, patient evaluated at discharge, 6 weeks, 3, 6, 12 and 24 months."
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to evaluate long-term safety and effectiveness of the NuNec\u00ae\n      Cervical Arthroplasty System in a small patient population.  The NuNec device is currently\n      CE marked and commercially available in Europe."
        }, 
        "brief_title": "Post-Market Study Evaluating the Safety and Effectiveness of NuNec\u00ae Cervical Arthroplasty System", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Cervical Intervertebral Disc Degeneration", 
        "condition_browse": {
            "mesh_term": "Intervertebral Disk Degeneration"
        }, 
        "detailed_description": {
            "textblock": "The NuNec\u00ae feasibility study is a prospective, multi-centered, non-randomized clinical\n      trial.  Only patients who have been diagnosed with single level, C3 to C7, symptomatic\n      cervical degenerative disc disease and have failed at least 6 weeks of conservative\n      treatment or present signs of progression of spinal cord/nerve root compression with\n      continued non-operative care will be enrolled.\n\n      Patients will be evaluated preoperatively and postoperatively at discharge, 6 weeks, 3, 6,\n      12 and 24 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  is at least 21 years of age and skeletally mature\n\n          -  must have symptomatic degenerative disc disease at one level in the        cervical\n             spine, C3 to C7, demonstrated by herniated disc and/or spondylosis;\n\n          -  must have completed a minimum of six weeks of unsuccessful conservative,\n             non-operative care or has the presence of progressive symptoms or signs of nerve\n             root/spinal cord compression in the face of conservative treatment\n\n          -  must score at least 15/50 (30%) on the Neck Disability Index\n\n          -  is willing and able to follow the post-operative management program\n\n          -  must understand and sign the informed consent document\n\n        Exclusion Criteria:\n\n          -  symptomatic cervical DDD at more than one level\n\n          -  axial neck pain as the primary diagnosis without evidence of neural compression\n\n          -  neck or arm pain of unknown etiology\n\n          -  any significant anatomical consideration which would make the anterior cervical\n             approach excessively risky or impossible\n\n          -  severe spondylosis at the target level\n\n          -  prior surgery at the target level\n\n          -  fused level adjacent to the target level\n\n          -  osteoporosis, osteopenia, osteomalacia, Paget's disease or metabolic bone disease\n\n          -  active infection or surgical site infection\n\n          -  is using any medication known to interfere with bone/soft tissue healing\n\n          -  diabetes mellitus requiring daily insulin management\n\n          -  any terminal, systemic, or autoimmune disease\n\n          -  medical conditions or mental incompetence which may interfere with study requirements\n\n          -  BMI >40 or a weight more than 100 lbs over ideal body weight\n\n          -  chemical dependency problem that may interfere with study requirements\n\n          -  current smokers\n\n          -  history of any invasive malignancy unless treated and in remission for at least two\n             years\n\n          -  documented allergies to metal or plastic\n\n          -  currently pregnant, or interested in becoming pregnant during the study follow-up"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01832818", 
            "org_study_id": "C01"
        }, 
        "intervention": {
            "arm_group_label": "NuNec Cervical Disc", 
            "description": "Patients will be enrolled and implanted with the NuNec device at a single level C3 to C7.", 
            "intervention_name": "NuNec Cervical Disc", 
            "intervention_type": "Device", 
            "other_name": "NuNec Cervical Arthroplasty System"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Total Disc Replacement", 
        "lastchanged_date": "April 28, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Leer", 
                        "country": "Germany"
                    }, 
                    "name": "Klinikum Leer"
                }, 
                "investigator": {
                    "last_name": "Hamid Fathi Afshar, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockton-on-Tees", 
                        "country": "United Kingdom"
                    }, 
                    "name": "University Hospital of North Tees"
                }, 
                "investigator": {
                    "last_name": "Tai Friesem, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Germany", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Feasibility, Multi-Center Nonrandomized Clinical Trial Evaluating the Safety and Effectiveness of NuNec\u00ae Cervical Arthroplasty System", 
        "overall_contact": {
            "email": "melindawooten@pioneersurgical.com", 
            "last_name": "Melinda Wooten", 
            "phone": "252-353-8204"
        }, 
        "overall_contact_backup": {
            "email": "emilydowns@pioneersurgical.com", 
            "last_name": "Emily Downs", 
            "phone": "906-225-5602"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United Kingdom: Research Ethics Committee", 
                "United Kingdom: National Health Service", 
                "Germany: Ethics Commission"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Neck disability index (NDI) score improvement of at least 15 points", 
                "safety_issue": "No", 
                "time_frame": "At 24 months as compared to baseline"
            }, 
            {
                "measure": "Visual analog scale (VAS) improvement of 2.0 cm for neck pain", 
                "safety_issue": "No", 
                "time_frame": "At 24 months"
            }, 
            {
                "description": "muscle strength, sensory function, gait analysis, and reflexes.", 
                "measure": "Maintenance or improvement in neurological status", 
                "safety_issue": "No", 
                "time_frame": "At 24 months compared to baseline"
            }, 
            {
                "measure": "No serious adverse events related to the device", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 24 months"
            }, 
            {
                "measure": "No device failures or removals, revisions, reoperations or supplemental fixation at the index level", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 24 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01832818"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Improvement in Neck Disability Index (NDI) by 15 points", 
                "safety_issue": "No", 
                "time_frame": "At 24 months"
            }, 
            {
                "measure": "A 10 point improvement in physical component score on SF-36 quality of life questionnaire.", 
                "safety_issue": "No", 
                "time_frame": "At 24 months"
            }, 
            {
                "description": "muscle strength, sensory function, gait analysis and reflexes.", 
                "measure": "Maintenance or improvement in neurological status", 
                "safety_issue": "No", 
                "time_frame": "At 24 month compared to baseline"
            }, 
            {
                "description": "As assessed on patient questionnaire.", 
                "measure": "Patient satisfaction", 
                "safety_issue": "No", 
                "time_frame": "At 24 months"
            }, 
            {
                "description": "Medication usage maintained or decreased from baseline.\nPatient returns to work or school with no deterioration in level of work activity compared to baseline.  If patient retires, reasons are unrelated to neck problems.", 
                "measure": "Medication usage and work status", 
                "safety_issue": "No", 
                "time_frame": "At 24 months"
            }, 
            {
                "measure": "Disc height is maintained", 
                "safety_issue": "No", 
                "time_frame": "At 24 months"
            }, 
            {
                "description": "Absence of device migration > 3mm; Absence of device subsidence > 3mm", 
                "measure": "Absence of device migration or subsidence", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 24 months"
            }
        ], 
        "source": "Pioneer Surgical Technology, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pioneer Surgical Technology, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}